After the Japan’s "law on ensuring the safety of regenerative medicine再生医療等の安全性の確保等に関する法律" was implemented in November 2014, immune cell therapy is widely used in university hospitals, clinics and other medical institution. However, the cell culture process must be standardized to ensure stable quality and efficient treatment results. Based on our high quality cell culture technology is being widely recognized and affirmed, BBT become the industry leader.
The company cooperate with 23 medical institutions in Japan from November 2022 in order to build the largest medical network of immune cell business in Japan. BBT will further strengthen the cooperation with more medical institutions, not only focusing on cancer treatment, but also aiming at on cancer prevention through ultra-early stage diagnosis of cancer combined with microRNA analysis.
With the application of big data, our exosome products use the most advanced and novel blockchain technology to trace the source and know its origin, and trace the source of its production. It helps to ensure that each single bottle of cultured stem cells is true and real and has the highest anti-counterfeiting effect.
Kyosei Medical Symbiology Institute Corporation leads the industry by its core technology of the entrusted business of stem cell culture. The most important include the culture of immune cells (BAK, NK, DC), third type regenerative medicine, fibroblasts, mesenchymal stem cells, second type regenerative medicine, etc. Manufacturing with a rigorous, high-quality and professional attitude, BBT provide cell processing technology (the third type of regenerative medicine) to medical institutions throughout Japan. Including but not limited to the hardware such as providing a high-quality cell culture technology, medical equipment, clean and sterilized room. BBT also serves in the software aspects of TQC, maintenance, SOP setting and build up. BBT has performed more than 16,000 cell culture implementations since opening. These high measurements and experiences are the reason for our highly entrusted and recognized by the medical industry.
